Gil Blum
Stock Analyst at Needham
(2.06)
# 2,887
Out of 4,876 analysts
390
Total ratings
35.14%
Success rate
-5.48%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Gil Blum
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRSP CRISPR Therapeutics AG | Reiterates: Buy | $81 | $46.70 | +73.45% | 23 | Jun 26, 2025 | |
| SRPT Sarepta Therapeutics | Maintains: Buy | $125 → $50 | $17.23 | +190.19% | 32 | Jun 16, 2025 | |
| AUTL Autolus Therapeutics | Reiterates: Buy | $10 | $2.31 | +332.90% | 28 | Jun 12, 2025 | |
| TSHA Taysha Gene Therapies | Reiterates: Buy | $8 | $2.41 | +231.95% | 28 | Jun 10, 2025 | |
| RCKT Rocket Pharmaceuticals | Downgrades: Hold | $42 | $2.59 | +1,521.62% | 21 | May 27, 2025 | |
| NKTX Nkarta | Maintains: Buy | $11 → $10 | $1.73 | +478.03% | 17 | May 15, 2025 | |
| CELC Celcuity | Reiterates: Buy | $29 | $11.98 | +142.17% | 16 | May 15, 2025 | |
| ARTV Artiva Biotherapeutics | Maintains: Buy | $23 → $18 | $1.57 | +1,046.50% | 6 | May 15, 2025 | |
| ABSI Absci | Reiterates: Buy | $9 | $2.71 | +232.10% | 4 | May 14, 2025 | |
| RNAC Cartesian Therapeutics | Maintains: Buy | $41 → $40 | $11.46 | +249.04% | 15 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $8 | $5.40 | +48.15% | 23 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $27 | $11.83 | +128.23% | 24 | Apr 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $1.48 | +508.11% | 7 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $1.00 | - | 16 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $2.80 | +150.00% | 18 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $105 | $64.77 | +62.11% | 23 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $0.46 | +769.57% | 9 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $1.10 | - | 8 | Jun 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $0.36 | +2,152.89% | 17 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $71 | $32.02 | +121.74% | 14 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $2.02 | +98.02% | 13 | Apr 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.53 | +226.80% | 22 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $5.69 | - | 6 | Feb 20, 2025 |
CRISPR Therapeutics AG
Jun 26, 2025
Reiterates: Buy
Price Target: $81
Current: $46.70
Upside: +73.45%
Sarepta Therapeutics
Jun 16, 2025
Maintains: Buy
Price Target: $125 → $50
Current: $17.23
Upside: +190.19%
Autolus Therapeutics
Jun 12, 2025
Reiterates: Buy
Price Target: $10
Current: $2.31
Upside: +332.90%
Taysha Gene Therapies
Jun 10, 2025
Reiterates: Buy
Price Target: $8
Current: $2.41
Upside: +231.95%
Rocket Pharmaceuticals
May 27, 2025
Downgrades: Hold
Price Target: $42
Current: $2.59
Upside: +1,521.62%
Nkarta
May 15, 2025
Maintains: Buy
Price Target: $11 → $10
Current: $1.73
Upside: +478.03%
Celcuity
May 15, 2025
Reiterates: Buy
Price Target: $29
Current: $11.98
Upside: +142.17%
Artiva Biotherapeutics
May 15, 2025
Maintains: Buy
Price Target: $23 → $18
Current: $1.57
Upside: +1,046.50%
Absci
May 14, 2025
Reiterates: Buy
Price Target: $9
Current: $2.71
Upside: +232.10%
Cartesian Therapeutics
May 8, 2025
Maintains: Buy
Price Target: $41 → $40
Current: $11.46
Upside: +249.04%
May 6, 2025
Maintains: Buy
Price Target: $11 → $8
Current: $5.40
Upside: +48.15%
Apr 29, 2025
Reiterates: Buy
Price Target: $27
Current: $11.83
Upside: +128.23%
Apr 8, 2025
Reiterates: Buy
Price Target: $9
Current: $1.48
Upside: +508.11%
Mar 27, 2025
Reiterates: Hold
Price Target: n/a
Current: $1.00
Upside: -
Jan 13, 2025
Reiterates: Buy
Price Target: $7
Current: $2.80
Upside: +150.00%
Dec 10, 2024
Reiterates: Buy
Price Target: $105
Current: $64.77
Upside: +62.11%
Aug 2, 2024
Reiterates: Buy
Price Target: $4
Current: $0.46
Upside: +769.57%
Jun 12, 2025
Reiterates: Hold
Price Target: n/a
Current: $1.10
Upside: -
May 8, 2025
Reiterates: Buy
Price Target: $8
Current: $0.36
Upside: +2,152.89%
Apr 10, 2025
Reiterates: Buy
Price Target: $71
Current: $32.02
Upside: +121.74%
Apr 4, 2025
Reiterates: Buy
Price Target: $4
Current: $2.02
Upside: +98.02%
Mar 12, 2025
Reiterates: Buy
Price Target: $5
Current: $1.53
Upside: +226.80%
Feb 20, 2025
Reiterates: Hold
Price Target: n/a
Current: $5.69
Upside: -